Diagnostics

Biden Administration Restarts Distribution Of Free At Home COVID-19 Tests, After Suspending For Year

COVID-19 Testing Lab In UK Misreported Several Positive Cases As Negative

EXCLUSIVE: Virax Biolabs Launches RSV/Flu/COVID-19 Combo Rapid Test Kit In Europe

COVID-19 Testing Lab In UK Misreported Several Positive Cases As Negative

EXCLUSIVE: Virax Biolabs Launches RSV/Flu/COVID-19 Combo Rapid Test Kit In Europe

Roche To Introduce Next-Generation Portfolio Of COVID-19 Rapid Tests

FDA To Review Smaller Number Of Emergency Use Requests For COVID-19 Tests

Roche To Introduce Next-Generation Portfolio Of COVID-19 Rapid Tests

FDA To Review Smaller Number Of Emergency Use Requests For COVID-19 Tests

Cue Health's Molecular COVID-19 Test At Par With Lab Based PCR Tests

Talis Biomedical Stops Work On COVID-19 Assay, Cuts Workforce

Diagnostics Recent News

FDA Gives Nod To First Nonprescription COVID-19 Test That Also Detects Flu, RSV

Quest Diagnostics' COVID-19 Testing Sales Decline 28% In Q1; Lifts FY22 EPS Guidance

UK-Based Start-Up Working On Next COVID-19 Vaccine Using Animal Feces: FT

Quest Diagnostics Secures CDC Contract To Support COVID-19 Research

Twist Bioscience Launches Synthetic RNA Positive Controls For SARS-CoV-2 Encapsulated Minicapsules

Twist Bioscience Corporation (NASDAQ: TWST) has

Manufacturing Bottlenecks Hit Launch Of Talis' FDA-Approved COVID-19 Test

Talis Biomedical Corp (NASDAQ: TLIS) said that it had

Lucira Health Terminates COVID-19 Test-Related Patent Agreement With Eiken Chemical

Twist Bioscience, Eleven Therapeutics Create Synthetic Viral RNA Molecules To Develop Antiviral Vaccines, Therapeutics

Twist Bioscience Corp (NASDAQ: TWST) and Eleven Therapeutics have created a replicon tool that could be used for studying viral genome replication, antiviral drug screening, and vaccine & therapeutic development.

Quest Diagnostics Stock Falls As FY22 EPS Outlook Lags Consensus

Medtronic Shares Fall After FDA Warning Letter To Its Diabetes Business

Medtronic Plc (NYSE: MDT)

Applied DNA Sciences' Q4 Revenues Skyrockets Buoyed By Momentum In COVID-19 Diagnostic Testing

Applied DNA Sciences Inc (NASDAQ: APDN) reported a more than ninefold Y/Y increase in Q4 FY21 revenues, driven by the rise in clinical laboratory service revenues related to COVID-19 testing.

FDA Enlists Thermo Fisher, Google-Backed Verily COVID-19 Tests Likely To Be Affected By Omicron

Biden's New COVID-19 Plan Includes Reimbursement For Over The Counter, At-Home COVID Tests

President Biden announced that private health

FDA Reissues Emergency Use Authorization For LumiraDx's COVID-19 Testing Solution

GBS Shares Are Rallying On Plans For COVID-19 Antibody Trials After Validation Study

GBS Inc (NASDAQ: GBS)

Valneva Recruits IDT Biologika As Manufacturing Partner For Its COVID-19 Vaccine

Valneva SE (NASDAQ: VALN) and IDT Biologika have announced their collaboration to produce Valneva's inactivated COVID-19 vaccine candidate VLA2001.

Chembio Diagnostics' DPP COVID-19 Antigen Test Approved In South Africa

South Africa Health Products Regulatory Authority (SAHPRA) has approved Chembio Diagnostics Inc's (NASDAQ: CEMI) DPP SARS-CoV-2 Antigen test for use at the point of care.

Applied DNA Stock Surges On Launch Plans For Linea 2.0 COVID-19 Assay For Omicron Variant

Applied DNA Sciences Inc (NASDAQ: APDN)

Thermo Fisher Says Its COVID-19 Tests Can Detect Omicron Variant

Thermo Fisher Scientific Inc (NYSE: TMO) said that its COVID-19 diagnostic tests can accurately detect the new coronavirus variant Omicron.

Qiagen Says Its COVID-19 PCR Tests Can Detect The New South African Variant

Qiagen N.V. (NYSE: QGEN) announced that its polymerase chain reaction (PCR)

Chembio Files For FDA Emergency Use Nod For COVID-19 Antigen Test

Medicare Coverage For Natera's Signatera For Pan-Cancer Immunotherapy Monitoring

Why Are Talis Shares Trading Higher Today?

;